JPRN-jRCT2033210424招募中未知
Postmarketing Surveillance Registry to evaluate safety and efficacy of Darvadstrocel for the treatment of complex perianal fistulas in Crohn's Disease Patients (J-INSPIRE) (All-case surveillance) - J-INSPIRE
Contact for Clinical Trial Information0 个研究点目标入组 275 人开始时间: 2021年11月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 275
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •All patients with complex perianal fistulas in Crohn's Disease who received Darvadstrocel will be included.
排除标准
- 未提供
研究者
相似试验
已完成
4 期
A post-marketing study of the marketed product Maxtra® P syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031189Zuventus Healthcare Limited200
已完成
4 期
A post-marketing study of the marketed product Maxtra® P Tablets for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031390Zuventus Healthcare Limited200
已完成
不适用
postmarketing surveillance For Investigating success in achieving clinical and functional Remission and Sustaining efficacy with Tocilizumab in BIOlogics naive RA patientsPatients with rheumatoid arthritis who have been diagnosed based on the 2010 ACR/EULAR new classification criteria for RA Patients who have no previous medical history of biological agents for RA Patients whose disease activity is DAS28>=3.2 at baselineJPRN-UMIN000006914Chugai Pharmaceutical Co. Ltd.700
已完成
4 期
Phase IV Clinical Trial to Evaluate the Efficacy and Safety of basic Fibroblast Growth Factor Compared to Placebo in Combination with NBUVB for the Treatment of VitiligoIRCT20201104049265N1Imen Vaccine Alborz88
已完成
4 期
A post marketing study to collect safety data of Gardasil when administered in routine practice to females between 9 to 45 years of ageCTRI/2015/09/006183MSD Pharmaceuticals PvtLtd